ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,684.01
      1.37%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      10/17/20124:39PMEdgar (US Regulatory)Registration of Additional Securities (up to 20%) (S-3MEF)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/17/20124:37PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/17/20124:13PMPR Newswire (US)Lexicon Announces Proposed Common Stock OfferingNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/16/20128:20AMMarketwiredFDA Considering Faster Pathway for Treatments of Deadly or Debilitating DiseasesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/12/20126:15AMPR Newswire (US)Lexicon Initiates Phase 3 Clinical Trial Of Telotristat Etiprate In Patients With Carcinoid SyndromeNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/12/20126:00AMPR Newswire (US)Second Phase 2 Trial Of Telotristat Etiprate Shows Positive Results In Carcinoid SyndromeNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/13/20128:20AMMarketwiredBiotech Industry Looks to Benefit From New Legislation Passed to Help Speed Up FDA Review ProcessNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/07/20126:00AMPR Newswire (US)Lexicon Pharmaceuticals To Present At The Morgan Stanley Global Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/31/20126:00AMPR Newswire (US)Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/16/20126:00AMPR Newswire (US)Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 StudiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/10/20126:00AMPR Newswire (US)Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/09/20126:00AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/07/20124:34PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/06/20124:20PMEdgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/02/20124:12PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/02/20124:10PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/01/20124:32PMEdgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/31/20128:26AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/31/20126:00AMPR Newswire (US)Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/20128:29AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/26/20124:17PMEdgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/24/20126:00AMPR Newswire (US)Lexicon to Provide Second Quarter 2012 Financial ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/18/20128:20AMMarketwiredLexicon Pharmaceuticals and Rosetta Genomics Showing Impressive Growth in 2012NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/03/20128:20AMMarketwiredBooming Biotech Industry a Hotbed of Merger & Acquisition Activity and Speculation in 2012NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/29/20126:00AMPR Newswire (US)Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Ph...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/28/20128:20AMMarketwiredBiotech Industry Home to Some of the Strongest Performers in 2012NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/25/20129:13AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/25/20126:00AMPR Newswire (US)Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/08/20126:00PMPR Newswire (US)Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association MeetingNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/30/20126:00PMPR Newswire (US)Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX